Amrutanjan Pharmaessense Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2016
- Revenue Growth -25.86%
- Profit Growth 16.70%
- Ebitda 28.15%
- Net Worth -18.71%
- Total Assets 6.22%
About Amrutanjan Pharmaessense
Amrutanjan Pharmaessense Private Limited (APPL) is Amalgamated company established on 21 Jan 2011 with its office registered at Chennai, Tamil Nadu, India and has been running since 14 Year, 1 Month with a paid up capital of 0.50 M. According to MCA records, 2 Directors are linked to this company as of 18 Jan 2025.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TN2011PTC078918
- Company No.
078918
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2011
- Date of AGM
21 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Amrutanjan Pharmaessense?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sambhuprasad Sivalenka  | Director | 21-Jan-2011 | Current |
Hanehallibhandimat Shetty  | Director | 21-Jan-2011 | Current |
Financial Performance of Amrutanjan Pharmaessense.
Amrutanjan Pharmaessense Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 25.86% decrease. The company also saw a substantial improvement in profitability, with a 16.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amrutanjan Pharmaessense?
In 2016, Amrutanjan Pharmaessense had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Amrutanjan Health Care Limited
Sambhuprasad Sivalenka is a mutual person
Goodhealth Holdings Private LimitedSambhuprasad Sivalenka is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amrutanjan Pharmaessense?
Amrutanjan Pharmaessense has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amrutanjan Pharmaessense, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amrutanjan Pharmaessense's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Amrutanjan Pharmaessense
Recent activity within the organization
- Annual General Meeting
Amrutanjan Pharmaessense Private Limited last Annual general meeting of members was held on 21 Sep 2016 as per latest MCA records.
- Balance Sheet
Amrutanjan Pharmaessense Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Chennai.
- Director Appointment
Sambhuprasad Sivalenka was appointed as a Director was appointed as a Director on 21 Jan 2011 & has been associated with this company since 14 years 1 month .
- Director Appointment
Hanehallibhandimat Narayan Shetty was appointed as a Director was appointed as a Director on 21 Jan 2011 & has been associated with this company since 14 years 1 month .
- Company Incorporation
Amrutanjan Pharmaessense Private Limited was registered on 21 Jan 2011 with Roc Chennai & aged 14 years 1 month as per MCA records.
Recent News, Updates & Announcement
Amrutanjan Healthcare strengthens focus on Health with Electro+, launches Low Sugar variant and ropes in Ruturaj Gaikwad as Brand Ambassador.National, 18 March 2024: Amrutanjan Healthcare, a renowned name in the healthcare and wellness industry, is proud to introduce the latest addition to its product line up – the low sugar variant of Electro+, an electrolyte drink designed to replenish .
- Amrutanjan Healthcare recognized as Best Healthcare Brand.
Amrutanjan Healthcare, a pioneering company with a 130-year history in India's healthcare industry, was bestowed with the esteemed Best Healthcare Brands felicitation at the 6th edition of The Economic Times Best Healthcare Brands event. Over the yea.
- Sebi imposes Rs 8 lakh fine on R S Agarwal.
India Business News: New Delhi, Dec 27 () Markets regulator Sebi today imposed a penalty of Rs 8 lakh on Emami chairman R S Agarwal in a matter related to Amrutanjan Healt.
Frequently asked questions
What is the Incorporation or founding date of Amrutanjan Pharmaessense Private Limited?
Amrutanjan Pharmaessense Private Limited was incorporated on 21 Jan 2011.
What is authorized share capital and paid-up capital of Amrutanjan Pharmaessense Private Limited?
The authorized share capital of Amrutanjan Pharmaessense Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Amrutanjan Pharmaessense Private Limited?
Currently 2 directors are associated with Amrutanjan Pharmaessense Private Limited.
- Sambhuprasad Sivalenka
- Hanehallibhandimat Narayan Shetty
What is the registered address of Amrutanjan Pharmaessense Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Amrutanjan Pharmaessense Private Limited is No.103 (Old No.42-45) Luz Church Road Mylapore, India, Chennai, Tamil Nadu, 600004.
What is the corporate identification number (CIN) and company number of Amrutanjan Pharmaessense Private Limited?
The corporate identification number (CIN) of Amrutanjan Pharmaessense Private Limited is U24232TN2011PTC078918 and the company number is 078918 as per Ministry of Corporate Affairs (MCA).
What is the official website of Amrutanjan Pharmaessense Private Limited?
The Official website of Amrutanjan Pharmaessense Private Limited is https://www.amrutanjan.com
What has been the recent revenue trend for Amrutanjan Pharmaessense Private Limited?
According to the financial reports for the fiscal year 2016, the revenue trend for Amrutanjan Pharmaessense Private Limited has fallen by -25.86%.
How many employees does Amrutanjan Pharmaessense Private Limited currently have?
As Per 2016 financial reports, 6 employees are currently employed by Amrutanjan Pharmaessense Private Limited.
What change has been observed in the net worth of Amrutanjan Pharmaessense Private Limited, and by what percentage?
The financial reports for the fiscal year 2016 indicates that The net worth of Amrutanjan Pharmaessense Private Limited has experienced an downturn of -18.71%.
When was the last Balance Sheet of Amrutanjan Pharmaessense Private Limited filed with the ROC?
The most recent Balance Sheet for Amrutanjan Pharmaessense Private Limited was filed with the ROC on 31 Mar 2016.